Guardant Health, Inc. (GH)

Guardant Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,861	3,775	3,283	2,786	10,168	12,884
Market Cap Growth	132.45%	14.96%	17.84%	-72.60%	-21.09%	75.59%
Enterprise Value	14,607	4,187	3,487	3,045	9,850	11,923
Last Close Price	107.58	30.55	27.05	27.20	100.02	128.88
PS Ratio	14.80	5.11	5.82	6.20	27.21	44.94
PB Ratio	-	-27.03	20.69	46.30	15.76	9.51
P/TBV Ratio	-	-	22.43	61.69	16.20	10.07
EV/Sales Ratio	16.18	5.67	6.18	6.77	26.36	41.58
Debt / Equity Ratio	-3.74	-9.57	8.53	22.75	2.13	0.63
Asset Turnover	0.64	0.45	0.33	0.24	0.17	0.18
Inventory Turnover	4.02	4.36	4.00	3.80	4.60	4.88
Quick Ratio	2.94	4.21	6.11	5.74	5.29	27.66
Current Ratio	3.50	4.68	6.54	6.17	5.72	28.27
Return on Equity (ROE)	-	-4584.47%	-438.12%	-185.65%	-38.46%	-22.35%
Return on Assets (ROA)	-19.64%	-16.95%	-17.71%	-17.84%	-11.48%	-9.85%
Return on Capital Employed (ROCE)	-42.50%	-35.20%	-30.50%	-38.40%	-20.40%	-11.60%
Earnings Yield	-2.88%	-11.56%	-14.60%	-23.49%	-3.99%	-1.97%
FCF Yield	-1.89%	-7.28%	-10.52%	-13.89%	-2.79%	-1.09%
Buyback Yield / Dilution	-2.22%	-9.61%	-9.60%	-0.85%	-3.91%	-7.62%

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q